Dapagliflozin to Prevent Anthracycline-Induced Cardiotoxicity

Clinical trial NCT06888505 · COMPLETED

Trial details

NCT number: NCT06888505
Sponsor: Hawler Medical University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anthracyclines-Induced Cardiotoxicity Cardiotoxicity

Start date: 2024-09-01
Primary completion: 2025-09-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.